Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only.All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

Thymalin_20MG

Thymalin

Thymalin is a low–molecular weight peptide complex originally isolated from thymic tissue and composed primarily of short regulatory peptides. In scientific research, Thymalin is utilized as a thymus-derived bioregulatory peptide preparation for studying immune signaling pathways, peptide-mediated gene regulation, and age-associated cellular communication in controlled experimental models.*

Unlike single-sequence synthetic peptides, Thymalin represents a defined mixture of short peptides that are believed to participate in thymus-related regulatory signaling. As such, it has been referenced in molecular biology, immunology, and gerontology research as a tool for investigating peptide-based regulation of cellular differentiation and immune-associated gene expression.*

  • Peptide Name: Thymalin
  • Peptide Class: Thymus-derived bioregulatory peptide complex
  • Composition: Short-chain regulatory peptides
  • Form: Lyophilized powder
  • Purity: ≥99% (by analytical verification of peptide content)
  • Quantity: 20 mg per vial
  • Analytical Verification: HPLC and Mass Spectrometry (MS)
  • Manufacturing: Controlled extraction and purification with in-house analytical validation
  • Designation: For Research Use Only (RUO)

$110.00

$104.50 each
$99.00 each

Products will arrive in a lyophilized (powder) form for maximum stability.

Free domestic shipping on orders over $300

Thymalin

Scientific & Research Context

Thymalin has been examined in published scientific literature for its role in peptide-mediated regulation of immune-related gene expression, thymus-associated cellular signaling, and age-dependent changes in immune system communication within experimental systems.*

In laboratory research environments, Thymalin has been utilized to investigate:*

  • Peptide regulation of immune and thymic signaling pathways*
  • Gene expression modulation in immune-related cell populations*
  • Cellular differentiation and proliferation signaling mechanisms*
  • Age-associated changes in peptide-mediated immune communication*
  • Structure–function relationships of thymus-derived regulatory peptides*

Due to its composition of short peptides and its reproducible biochemical profile, Thymalin is frequently used in experimental models focused on peptide signaling, immunoregulation research, and molecular gerontology.*

Quality & Analytical Assurance

Each batch of Thymalin undergoes rigorous analytical testing to confirm peptide composition, molecular integrity, and purity. Verification using validated HPLC and MS methodologies ensures batch-to-batch consistency, reproducibility, and suitability for controlled research applications.

Storage & Handling

Thymalin is supplied in lyophilized form to enhance stability during storage and shipping. Store unopened vials in a cool, dry environment protected from light. Reconstitution and handling should follow established peptide research and laboratory best practices to preserve molecular integrity and minimize degradation.

For further information on proper storage techniques, click the button…

Storage Instructions

Referenced Scientific Literature
Provided for informational and educational purposes only

  • Khavinson VK, Morozov VG. Peptides of the thymus: structure and function. Biull Eksp Biol Med., 1983;95(4):5–8.
  • Khavinson VK, Kvetnoi IM, Linkova NS. Peptide regulation of immune system aging. Adv Gerontol., 2003;13:58–65.
  • Khavinson VK, Lindner H. Short peptides as regulators of gene expression. Neurochemical Journal, 2009;3(4):229–236.
  • Morozov VG, Khavinson VK. Natural regulatory peptides: bioregulators of immune and endocrine systems. Biochemistry (Moscow), 1997;62(9):1031–1040.
  • Khavinson VK, Malinin VV. Gerontological aspects of peptide regulation of immunity. Bull Exp Biol Med., 2002;133(4):367–371.
  • Kvetnoi IM, Linkova NS, Khavinson VK. Peptide regulation of thymus-dependent immune responses during aging. Adv Gerontol., 2007;20(1):16–22.
  • Khavinson VK, Tarnovskaya SI. Regulatory peptides of thymus and their role in cellular differentiation. Biull Eksp Biol Med., 1984;98(11):579–582.
  • Anisimov VN, Khavinson VK. Peptides and aging: experimental and clinical aspects. Exp Gerontol., 2010;45(7–8):475–480.
  • Linkova NS, Polyakova VO, Kheifets OV, Khavinson VK. Peptide regulation of gene expression in immune system cells. Bull Exp Biol Med., 2011;150(6):731–734.
  • Khavinson VK, Grigoriev PA. Short peptides as epigenetic regulators of cell function. Neurochemical Journal, 2015;9(2):103–110.
  • Bach J., Bardenne M., Pleau J., Rosa J. Biochemical characterisation of a serum thymic factor. Nature, 1977; 266(5597): 55–57.
  • Hrinevych I. I., Bendiuh H. D., Khranovs’ka N. M., Bilokin’ I. M., Ostapenko O. M. Effect of thyroxin and thymalin on proliferation and apoptosis of thymocytes in rats after thyroidectomy. Fiziolohichnyi Zhurnal, 2004; 50(3): 39–43.
  • Zhukova G. V., Schikhlyarova A. I., Barteneva T. A., Shevchenko A. N., Zakharyuta F. M. Effect of Thymalin on the tumor and thymus under conditions of activation therapy in vivo. Bulletin of Experimental Biology and Medicine, 2018; 165(1): 80–83.
  • Labunets’ I. F. Age-related changes in circadian and circannual fluctuations of the immune response and the number of cells in lymphoid organs of animals: a possible connection to thymic factors. Fiziolohichnyi Zhurnal, 2001; 47(5): 54–62.
  • Ryzhenkov V. E., Ogurtsov R. P., Trubacheva V. V., Popov V. G., Puzyreva V. P. Effect of thymalin on the development of experimental hyperlipidemia and atherosclerosis. Voprosy Meditsinskoi Khimii, 1988; 34(1): 51–56.
  • Wade S., et al. Thymulin (zinc-dependent thymic serum factor) activity in patients with anorexia nervosa. American Journal of Clinical Nutrition, 1985; 42(2): 275–280.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.